Treatment outcomes with hypofractionated high-dose radiation therapy for prostate cancer

about

eRAPID electronic patient self-Reporting of Adverse-events: Patient Information and aDvice: a pilot study protocol in pelvic radiotherapy.

P2860

Q55491469-1AA22BB8-6090-4A82-9135-91B2677A0FEF

P2860

Treatment outcomes with hypofractionated high-dose radiation therapy for prostate cancer

Item

http://www.wikidata.org/entity/Q40959922

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Treatment outcomes with hypofractionated high-dose radiation therapy for prostate cancer

@en

type

Item

label

Treatment outcomes with hypofractionated high-dose radiation therapy for prostate cancer

@en

prefLabel

Treatment outcomes with hypofractionated high-dose radiation therapy for prostate cancer

@en

P1476

Treatment outcomes with hypofractionated high-dose radiation therapy for prostate cancer

@en

P2093

Bruno Tiago Rossi

http://www.w3.org/2001/XMLSchema#string

Eduardo Jose Stefano

http://www.w3.org/2001/XMLSchema#string

Elton Suguikawa

http://www.w3.org/2001/XMLSchema#string

Gisele Zuliani

http://www.w3.org/2001/XMLSchema#string

Gustavo Arruda Viani

http://www.w3.org/2001/XMLSchema#string

P2860

Higher-than-conventional radiation doses in localized prostate cancer treatment: a meta-analysis of randomized, controlled trials.

Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/american college of radiology 95-09

Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference.

Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy.

Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer.

Pelvic normal tissue contouring guidelines for radiation therapy: a Radiation Therapy Oncology Group consensus panel atlas

Early closure of phase II prospective study on acute and late tolerance of hypofractionated radiotherapy in low-risk prostate cancer patients.

Hypofractionated radiation therapy (66 Gy in 22 fractions at 3 Gy per fraction) for favorable-risk prostate cancer: long-term outcomes.

Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5,969 patients in seven international institutional datasets: α/β = 1.4 (0.9-2.2) Gy.

Patient costs associated with external beam radiotherapy treatment for localized prostate cancer: the benefits of hypofractionated over conventionally fractionated radiotherapy.

P304

162-167

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.RPOR.2015.12.003

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-02-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

294110327

http://www.w3.org/2001/XMLSchema#string

P698

27601945

http://www.w3.org/2001/XMLSchema#string

P932

5002023

http://www.w3.org/2001/XMLSchema#string

Treatment outcomes with hypofractionated high-dose radiation therapy for prostate cancer

about

P2860

P2860

Treatment outcomes with hypofractionated high-dose radiation therapy for prostate cancer

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932